Ashley Cordova

2021

In 2021, Ashley Cordova earned a total compensation of $5.5M as Chief Financial Officer at NovoCure, a 69% increase compared to previous year.

Compensation breakdown

Option Awards$1,664,746
Salary$477,500
Stock Awards$3,333,248
Other$8,950
Total$5,484,444

Cordova received $3.3M in stock awards, accounting for 61% of the total pay in 2021.

Cordova also received $1.7M in option awards, $477.5K in salary and $9K in other compensation.

Rankings

In 2021, Ashley Cordova's compensation ranked 2,333rd out of 12,405 executives tracked by ExecPay. In other words, Cordova earned more than 81.2% of executives.

ClassificationRankingPercentile
All
2,333
out of 12,405
81st
Division
Manufacturing
913
out of 5,494
83rd
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
97
out of 798
88th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
62
out of 519
88th
Industry
Surgical and Medical Instruments and Apparatus
41
out of 324
87th
Source: SEC filing on April 25, 2022.

Cordova's colleagues

We found four more compensation records of executives who worked with Ashley Cordova at NovoCure in 2021.

2021

Wilhelmus Groenhuysen

NovoCure

Chief Operating Officer

2021

Pritesh Shah

NovoCure

Chief Commercial Officer

2021

Todd Longsworth

NovoCure

General Counsel

2021

Asaf Danziger

NovoCure

Chief Executive Officer

News

You may also like